Tag: chimeric antigen receptor
TGA OKs Novartis CAR-T cell therapy manufacturing in Melbourne
With TGA approval in check, Melbourne will house Australia's first and only commercial manufacturing site for the promising cancer treatment.
Swiss pharmaceutical company Novartis announced...
Featured Article
How Taiwan is revolutionising its AI data centres with liquid cooling
The rapid advancement of artificial intelligence relies heavily on the infrastructure that supports it. As AI continues to transform industries worldwide, the demand for robust and efficient data centre operations has never been more critical. This, in turn, has brought attention to the environmental impact of these facilities.
